Brief: China Regenerative Medicine International Posts Qtrly Loss Attributable HK$22.2 Mln
11/11/2019 05:02
Nov 11 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* QTRLY LOSS ATTRIBUTABLE HK$22.2 MILLION VERSUS LOSS OF
HK$56.3
MILLION
* QTRLY REVENUE HK$13 MILLION VERSUS HK$9.2 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS1pn8g3
Further company coverage: 8158.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital